Results 161 to 170 of about 8,147 (216)
Some of the next articles are maybe not open access.
Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis
Annals of Surgical Oncology, 2007Peritonectomy with heated intraperitoneal chemotherapy (HIPEC) has shown a survival benefit in selected patients with peritoneal carcinomatosis. This prospective non-randomized study was designed to identify factors associated with postoperative morbidity and survival after peritonectomy HIPEC in patients with this condition.Data were prospectively ...
B L, van Leeuwen +3 more
openaire +2 more sources
2021
Peritoneal carcinomatosis and peritoneal sarcomatosis in children are rare and might occur in colorectal cancer, desmoplastic small round cell tumors (DSRCT), rhabdomyosarcoma, and other entities. The treatment of these children is still a major challenge as despite very intensive therapies consisting of systemic chemotherapy, radiotherapy, and surgery,
Guido Seitz, Jörg Fuchs, Stefan Beckert
openaire +1 more source
Peritoneal carcinomatosis and peritoneal sarcomatosis in children are rare and might occur in colorectal cancer, desmoplastic small round cell tumors (DSRCT), rhabdomyosarcoma, and other entities. The treatment of these children is still a major challenge as despite very intensive therapies consisting of systemic chemotherapy, radiotherapy, and surgery,
Guido Seitz, Jörg Fuchs, Stefan Beckert
openaire +1 more source
Rationale Behind HIPEC/Molecular and Genetic Considerations in HIPEC
2019The series of molecular events comprising the metastatic cascade in peritoneal carcinomatosis is complex. The tumor microenvironment is rich in factors regulating cell proliferation, DNA repair, and senescence. Combined hyperthermia and intraperitoneal chemotherapy are utilized in conjunction with cytoreductive surgery for peritoneal surface ...
Jula Veerapong, Andrew M. Lowy
openaire +1 more source
2019
Synchronous intra-parenchymal hepatic involvement (HI) in patients with peritoneal disease (PD) has traditionally served as a contraindication for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, several studies have demonstrated the feasibility and safety of combined liver resection with CRS/HIPEC in well ...
Laura M. Enomoto +3 more
openaire +1 more source
Synchronous intra-parenchymal hepatic involvement (HI) in patients with peritoneal disease (PD) has traditionally served as a contraindication for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, several studies have demonstrated the feasibility and safety of combined liver resection with CRS/HIPEC in well ...
Laura M. Enomoto +3 more
openaire +1 more source
Application of IPC, HIPEC, and PIPAC
2021The combination of cytoreductive surgery and intraperitoneal chemotherapy has demonstrated very promising clinical results in patients with peritoneal carcinomatosis. The underlying rationale for intraperitoneal chemotherapy is dose intensification.
Kurt Van der Speeten +2 more
openaire +1 more source